Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity
  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search
  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search
  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

Rabbit Anti-PAK1, PAK2, PAK3 monoclonal antibody, clone TV14-81


Creative Diagnostics logo
View Antibody details

Rabbit Anti-PARK monoclonal antibody, clone KG93-10


Creative Diagnostics logo
View Antibody details

Rabbit Anti-PARK7 monoclonal antibody, clone TO18-32


Creative Diagnostics logo
View Antibody details

Rabbit Anti-PARP monoclonal antibody, clone TV14-79


Creative Diagnostics logo
View Antibody details

Rabbit Anti-PAX5 monoclonal antibody, clone KK19-98


Creative Diagnostics logo
View Antibody details

Rabbit Anti-PAX6 monoclonal antibody, clone TE19-42


Creative Diagnostics logo
View Antibody details

Rabbit Anti-PAX6 monoclonal antibody, clone TE192-14


Creative Diagnostics logo
View Antibody details

Rabbit Anti-PAX7 monoclonal antibody, clone TE194-15


Creative Diagnostics logo
View Antibody details

Rabbit Anti-PAX9 monoclonal antibody, clone TE193-13


Creative Diagnostics logo
View Antibody details

Rabbit Anti-PCNA monoclonal antibody, clone TZ23-18


Creative Diagnostics logo
View Antibody details